116 related articles for article (PubMed ID: 8300642)
21. The inflammatory cytokine oncostatin M induces PAI-1 in human vascular smooth muscle cells in vitro via PI 3-kinase and ERK1/2-dependent pathways.
Demyanets S; Kaun C; Rychli K; Rega G; Pfaffenberger S; Afonyushkin T; Bochkov VN; Maurer G; Huber K; Wojta J
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1962-8. PubMed ID: 17604327
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells.
Yue TL; Wang X; Sung CP; Olson B; McKenna PJ; Gu JL; Feuerstein GZ
Circ Res; 1994 Jul; 75(1):1-7. PubMed ID: 8013067
[TBL] [Abstract][Full Text] [Related]
23. Enhancement by sphingosine 1-phosphate in vasopressin-induced phosphoinositide hydrolysis in aortic smooth-muscle cells: involvement of p38 MAP kinase.
Kozawa O; Yamamoto T; Tanabe K; Akamatsu S; Dohi S; Uematsu T
J Cell Biochem; 2000 Sep; 80(1):46-52. PubMed ID: 11029753
[TBL] [Abstract][Full Text] [Related]
24. Vasopressin induces arachidonic acid release through pertussis toxin-sensitive GTP-binding protein in aortic smooth muscle cells: independence from phosphoinositide hydrolysis.
Ito Y; Kozawa O; Tokuda H; Kotoyori J; Oiso Y
J Cell Biochem; 1993 Oct; 53(2):169-75. PubMed ID: 8227189
[TBL] [Abstract][Full Text] [Related]
25. Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders.
Kanse SM; Benzakour O; Kanthou C; Kost C; Lijnen HR; Preissner KT
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2848-54. PubMed ID: 9409265
[TBL] [Abstract][Full Text] [Related]
26. Tissue factor pathway inhibitor-2 is a novel mitogen for vascular smooth muscle cells.
Shinoda E; Yui Y; Hattori R; Tanaka M; Inoue R; Aoyama T; Takimoto Y; Mitsui Y; Miyahara K; Shizuta Y; Sasayama S
J Biol Chem; 1999 Feb; 274(9):5379-84. PubMed ID: 10026147
[TBL] [Abstract][Full Text] [Related]
27. Epigallocatechin suppression of proliferation of vascular smooth muscle cells: correlation with c-jun and JNK.
Lu LH; Lee SS; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1227-37. PubMed ID: 9720795
[TBL] [Abstract][Full Text] [Related]
28. Gene response of human skin fibroblasts to urokinase- and tissue-type plasminogen activators.
Copeta A; Tavian D; Marchina E; De Petro G; Barlati S
Growth Factors; 2000; 17(4):249-68. PubMed ID: 10801075
[TBL] [Abstract][Full Text] [Related]
29. Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
Atherosclerosis; 2001 Mar; 155(1):37-44. PubMed ID: 11223424
[TBL] [Abstract][Full Text] [Related]
30. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
Wojta J; Gallicchio M; Zoellner H; Hufnagl P; Last K; Filonzi EL; Binder BR; Hamilton JA; McGrath K
Thromb Haemost; 1993 Sep; 70(3):469-74. PubMed ID: 8259551
[TBL] [Abstract][Full Text] [Related]
31. Regulation of baboon arterial smooth muscle cell plasminogen activators by heparin and growth factors.
Kenagy RD; Clowes AW
Thromb Res; 1995 Jan; 77(1):55-61. PubMed ID: 7701477
[TBL] [Abstract][Full Text] [Related]
32. Interaction of atrial natriuretic polypeptide and angiotensin II on protooncogene expression and vascular cell growth.
Itoh H; Pratt RE; Dzau VJ
Biochem Biophys Res Commun; 1991 May; 176(3):1601-9. PubMed ID: 1828153
[TBL] [Abstract][Full Text] [Related]
33. Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery.
Clowes AW; Clowes MM; Kirkman TR; Jackson CL; Au YP; Kenagy R
Circ Res; 1992 Jun; 70(6):1128-36. PubMed ID: 1374298
[TBL] [Abstract][Full Text] [Related]
34. Plasmin-mediated fibroblast growth factor-2 mobilisation supports smooth muscle cell proliferation in human saphenous vein.
George SJ; Johnson JL; Smith MA; Jackson CL
J Vasc Res; 2001; 38(5):492-501. PubMed ID: 11561151
[TBL] [Abstract][Full Text] [Related]
35. Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells.
Sironi L; Calvio AM; Arnaboldi L; Corsini A; Parolari A; de Gasparo M; Tremoli E; Mussoni L
Hypertension; 2001 Mar; 37(3):961-6. PubMed ID: 11244025
[TBL] [Abstract][Full Text] [Related]
36. Sphingosylphosphorylcholine stimulates mitogen-activated protein kinase via a Ca2+-dependent pathway.
Chin TY; Chueh SH
Am J Physiol; 1998 Nov; 275(5):C1255-63. PubMed ID: 9814974
[TBL] [Abstract][Full Text] [Related]
37. Monocyte chemotactic protein 1 amplifies serotonin-induced vascular smooth muscle cell proliferation.
Watanabe T; Pakala R; Katagiri T; Benedict CR
J Vasc Res; 2001; 38(4):341-9. PubMed ID: 11455205
[TBL] [Abstract][Full Text] [Related]
38. Activated alpha 2-macroglobulin promotes mitogenesis in rat vascular smooth muscle cells by a mechanism that is independent of growth-factor-carrier activity.
Webb DJ; Hussaini IM; Weaver AM; Atkins TL; Chu CT; Pizzo SV; Owens GK; Gonias SL
Eur J Biochem; 1995 Dec; 234(3):714-22. PubMed ID: 8575427
[TBL] [Abstract][Full Text] [Related]
39. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
40. Growth factor activity of endothelin on vascular smooth muscle.
Bobik A; Grooms A; Millar JA; Mitchell A; Grinpukel S
Am J Physiol; 1990 Mar; 258(3 Pt 1):C408-15. PubMed ID: 1690514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
